Danaher Corp., a healthcare group, is acquiring Nobel Biocare Holding AG for $2.2 billion. The deal makes Danaher the biggest company in the dental implants market with has seen demand rise in recent years for cosmetic dentistry. Danaher will pay 17 Swiss francs per share to buy Noble Biocare which is a 23% premium from its closing price on July 28th when the company first announced it looking for possible buyers. Shares for Noble Biocare has dropped because analysts were expecting the company would fetch more than 20 francs per share. Sebastien Buch, a manager at Union Investment said, "From my side, it doesn't fill me with that much enthusiasm. But I don't expect there will be a second bid."